Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
RPL22L1 - Cyclin-dependent kinase inhibitor R547 effect on prostate cancer cell line: dose response and time course
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
SNORA41 - Cyclin-dependent kinase inhibitor R547 effect on prostate cancer cell line: dose response and time course
ACTB - Cyclin-dependent kinase inhibitor R547 effect on prostate cancer cell line: dose response and time course
Cyclin-dependent kinase inhibitor R547 effect on prostate cancer cell line: dose response and time course
GEO DataSets Profile neighbors
C1QBP - Cyclin-dependent kinase inhibitor R547 effect on prostate cancer cell line: dose response and time course
LOC101927137 - Cyclin-dependent kinase inhibitor R547 effect on prostate cancer cell line: dose response and time course
MCM7 - Cyclin-dependent kinase inhibitor R547 effect on prostate cancer cell line: dose response and time course
LOC101060363 - Cyclin-dependent kinase inhibitor R547 effect on prostate cancer cell line: dose response and time course
ODC1 - Cyclin-dependent kinase inhibitor R547 effect on prostate cancer cell line: dose response and time course
NME1 - Cyclin-dependent kinase inhibitor R547 effect on prostate cancer cell line: dose response and time course
EIF3J - Cyclin-dependent kinase inhibitor R547 effect on prostate cancer cell line: dose response and time course
ENOPH1 - Cyclin-dependent kinase inhibitor R547 effect on prostate cancer cell line: dose response and time course
NOLC1 - Cyclin-dependent kinase inhibitor R547 effect on prostate cancer cell line: dose response and time course
ALYREF - Cyclin-dependent kinase inhibitor R547 effect on prostate cancer cell line: dose response and time course
UNG - Cyclin-dependent kinase inhibitor R547 effect on prostate cancer cell line: dose response and time course
TFRC - Cyclin-dependent kinase inhibitor R547 effect on prostate cancer cell line: dose response and time course
HAUS2 - Cyclin-dependent kinase inhibitor R547 effect on prostate cancer cell line: dose response and time course
WDR66 - Cyclin-dependent kinase inhibitor R547 effect on prostate cancer cell line: dose response and time course
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on